Vimarsana
Biggest News Aggregation in the World

Page 2 - World Effectiveness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from World Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In World Effectiveness Today - Breaking & Trending Today

How Antibody Drug Conjugates—and Chemotherapy Shortages—Are Affecting Patients With Bladder Cancer - Vimarsana News

How Antibody Drug Conjugates—and Chemotherapy Shortages—Are Affecting Patients With Bladder Cancer

Published: August 4, 2023

Coverage from the July 25, 2023, Institute for Value-Based Medicine® session held in partnerhship with Emory's Winship Cancer Institute.

Source: ajmc.com
Related Topics:
United StatesPaul EhrlichKumar PalEmory Jacquelinet BrownWinship Cancer InstituteScience History InstituteInstitute For ValueAmerican Hospital AssociationAmerican Society Of Clinical OncologyDrug ConjugatesAdvanced Urothelial CarcinomaValue Based MedicineAmerican JournalManaged CareHoly GrailAmerican SocietyClinical OncologyScience HistoryAccessed AugustWorld EffectivenessElderly Patients With Metastatic Bladder Cancer
Teva's 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine - Vimarsana News

Teva's 3rd interim analysis of PEARL real-world study on AJOVY® (fremanezumab) reveals sustained long-term effectiveness in reducing frequency, duration and severity of attacks in patients with chronic and episodic migraine

Published: June 30, 2023

Data presented at the European Academy of Neurology Congress 2023

Source: marketscreener.com
Related Topics:
Pinar KokturkCristina TassorelliBehavioural SciencesUniversity Of PaviaTeva Pharmaceutical Industries LtdEuropean Headache FederationHead Of Medical Affairs Europe At TevaInternational Headache Society Clinical Trials Standing CommitteeEuropean Academy Of NeurologyDepartment Of BrainGuidelines Of The International Headache SocietyTeva Pharmaceutical IndustriesEuropean AcademyProfessor Cristina TassorelliProfessor TassorelliMedical Affairs EuropePan European Real WorldPharmaceutical IndustriesPrivate Securities Litigation Reform ActQuarterly ReportAnnual ReportReal WorldPersistence AlongConcomitant Migraine Medication UseFremanezumab Initiation
Links 3/30/2023 | naked capitalism - Vimarsana News

Links 3/30/2023 | naked capitalism

Published: March 30, 2023

Our sulfite-free daily links

Source: nakedcapitalism.com
Related Topics:
United KingdomUnited StatesFrance GeneralRand PaulAudrey Elizabeth HaleHenry KissingerSam AltmanPaul KrugmanEric TopolJamelle BouieClub Of Rome EarthCredit SuisseCovenant SchoolRoyal United Services Institute For DefenceSouth China Morning PostBiden AdministrationAi Snake OilRussia Foreign AffairsStrange AccelerationGuy BoughtFlatiron BuildingDidnt PayGreat Salt LakeHigh CountryOhio River
AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting - Vimarsana News

AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting

Published: November 22, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 65 company and partner abstracts across 8 types of cancer during the upcoming American...

Source: prnewswire.com
Related Topics:
United StatesNew OrleansAcalabrutinib MonotherapyGilteritinib VenetoclaxObinutuzumab ClbMohamed ZakiFludarabine Cytarabine Gemtuzumab OzogamycinEpcoritamab MonotherapyJanssen Biotech IncHealth ServicesAmerican Society Of HematologyHealth AuthorityStudy GroupDrug AdministrationOutcomes ResearchHealth Care Resource UtilizationRoche GroupAmerican Society Of HemaotologyBlood CancerAmerican SocietyNon Hodgkins LymphomasLargeb Cell LymphomaFollicular LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting - Vimarsana News

AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting

Published: November 22, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 65 company and partner abstracts across 8 types of cancer during the upcoming American...

Source: prnewswire.com
Related Topics:
United StatesNew OrleansAcalabrutinib MonotherapyGilteritinib VenetoclaxObinutuzumab ClbMohamed ZakiFludarabine Cytarabine Gemtuzumab OzogamycinEpcoritamab MonotherapyJanssen Biotech IncHealth ServicesAmerican Society Of HematologyHealth AuthorityStudy GroupDrug AdministrationOutcomes ResearchHealth Care Resource UtilizationRoche GroupAmerican Society Of HemaotologyBlood CancerAmerican SocietyNon Hodgkins LymphomasLargeb Cell LymphomaFollicular LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia